SUMMARY
Dihydropyridine (DHP) Ca2+ channel blockers decrease L-type Ca 2+ channel current (I CaL ) by enhancing steady-state inactivation, whereas β-adrenergic stimulation increases I CaL with small changes in the kinetics. We studied the effects of DHP Ca 2+ channel blockers on cardiac I CaL augmented by β-adrenergic stimulation. We recorded I CaL as Ba 2+ currents (I Ba ) from guinea pig ventricular myocytes using the whole-cell patch clamp technique, and compared the effects of nitrendipine (NIT) in the absence and presence of isoproterenol (1 µM, ISO) or forskolin (10 µM, FSK). Maximal I Ba elicited from a holding potential of -80 mV were diminished to 69.4±13.5% (mean and SE, n=5) of control by NIT (100 nM) and the diminished I Ba were increased to 180.3±23.2% of control by ISO in the presence of NIT, which was similar to the enhancement seen in the absence of NIT. NIT shifted the V 1/2 of the I Ba inactivation curve from -34.6±1.9 mV (n=5) to -48.7±1.2 mV, enhancing I Ba decay with shortening T 1/2 at -10 mV from 164.6±24.2 ms (n=7) to 105.4±15.2 ms. ISO elicited a small additional shift in the V 1/2 of I Ba inactivation in the same direction. ISO and FSK each slowed I Ba decay in the absence of NIT, but not in its presence. Thus, β-adrenergic agonists increase and DHP Ca 2+ channel blockers decrease the amplitude of cardiac I CaL independently and the kinetics of I CaL is determined mainly by the latter when these drugs coexist. ( 1,2) They act by depressing L-type Ca 2+ channel currents (I CaL ), which play key roles in excitation-contraction coupling in cardiac and vascular smooth muscle cells (VSM), thereby exhibiting negative inotropic and vasodilatory actions. DHP Ca 2+ channel blockers inhibit I CaL in VSM more readily than in cardiac muscle as a consequence of differences in the resting membrane potentials, which are more